Thierry Uh

Thierry Uh has extensive work experience in the pharmaceutical industry. Thierry currently serves as the President of Daewoong Innovation Holdings, Inc. since May 2021. Prior to this, they were a Director at AffyXell Therapeutics, Co., Ltd. starting in February 2020. Thierry also held the position of Head of Business Development at Daewoong Pharmaceuticals from January 2018. Before that, they worked at Dong-A Socio Holdings as a Manager in the Corporate Strategy Office, where they were responsible for strategy formulation, implementation, strategic investment, and acquisition. Thierry began their career as a License Manager at Dong-A Pharmaceuticals in March 2010 and worked there until July 2014.

Thierry Uh attended Chungnam National University from 1999 to 2006, where they obtained a DVM (Doctor of Veterinary Medicine) degree in Veterinary Medicine. Thierry then pursued an MSc degree in Physiology from Seoul National University from 2006 to 2008. Later, Thierry Uh undertook further education in Advanced Clinical Pharmacy at Seoul National University from 2011 to 2012. Thierry also holds additional certifications, including an MSc from Seoul National University in 2008 and a DVM from MAFRA in 2006.